ArticleJCO global oncology2020
Recommendations from the ASCO Academic Global Oncology Task Force.
Article in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Trainee and Faculty Perspectives on Global Oncology: Assessing Interest, Barriers, and Opportunities.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026Article
- Barriers to advancing global oncology in an NCI-designated cancer center: A cross-sectional survey of faculty perspectives.Global health & medicine · 2026Article
- Provincialising Global Oncology.BMJ global health · 2025Article
- Growing Interest in Global Health Among Trainees: The Need for Increasing Training Opportunities for Residents and Fellows in Oncology.Global health, epidemiology and genomics · 2025Article
- Integrating Health Equity in the ASCO Guideline Agenda: Recommendations From Members of the Palliative Care Expert Panel.JCO oncology practice · 2024Article
- Cancer treatments: Past, present, and future.Cancer genetics · 2024Review
- Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO.JCO global oncology · 2024Article
- Authorship of Publications Supported by NCI-Funded Grants Involving Low- and Middle-Income Countries.JAMA network open · 2024Article
- Advancing Global Oncology Readership Needs: Pushing Forward Since 2015.JCO global oncology · 2023Article
- Characterization of Oncology Clinical Trials Using Germline Genetic Data.JAMA network open · 2022Article
- Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement.The Lancet. Oncology · 2022Article
- Global Oncology Authorship and Readership Patterns.JCO global oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recognition of the rising incidence and mortality of cancer in low- and middle-resource settings, as well as the increasingly international profile of its membership, ASCO has prioritized efforts to enhance its engagement at a global level. Among the recommendations included in the 2016 Global Oncology Leadership Task Force report to the ASCO Board of Directors was that ASCO should promote the recognition of global oncology as an academic field. The report suggested that ASCO could serve a role in transitioning global oncology from an informal field of largely voluntary activities to a more formal discipline with strong research and well-defined training components. As a result of this recommendation, in 2017, ASCO formed the Academic Global Oncology Task Force (AGOTF) to guide ASCO's contributions toward formalizing the field of global oncology. The AGOTF was asked to collect and analyze key issues and barriers toward the recognition of global oncology as an academic discipline, with an emphasis on training, research, and career pathways, and produce a set of recommendations for ASCO action. The outcome of the AGOTF was the development of recommendations designed to advance the status of global oncology as an academic discipline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.